Analytical Evaluation of Point-of-Care FinecareTM Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys® BRAHMS Procalcitonin Immunoassay

Mohd Zulfakar Mazlan,Wan Norlina Wan Azman,Najib Majdi Yaacob,Tan Say Koon,Nurul Khaiza Yahya
DOI: https://doi.org/10.3390/diagnostics14111080
IF: 3.6
2024-05-23
Diagnostics
Abstract:The study compared two plasma procalcitonin (PCT) assays, the point of care (POC) FinecareTM Procalcitonin Rapid Quantitative Test and the Elecsys® BRAHMS PCT immunoassay, in sepsis ICU patients. Forty-one plasma samples were analyzed, showing a strong correlation (r = 0.98) and no significant difference in PCT values. The mean POC PCT value was 4.46 ng/mL (SD 8.68), and for laboratory BRAHMS PCT, it was 4.67 ng/mL (SD 10.03). The study found a strong linear relationship between plasma POC PCT and laboratory BRAHMS PCT (r = 0.98). Different regression methods showed varying intercepts and slopes: Ordinary Least Squares had an intercept of 0.49 and a slope of 0.85; Deming regression showed an intercept of 0.43 and a slope of 0.86; Passing–Bablok regression showed an intercept of 0.02 and a slope of 1.08. Precision results for cut-offs of 0.5 ng/mL were a coefficient of variation (CV) of 5%, and for 2.5 ng/mL, the CV was 2.5%. The Pearson correlation coefficient (r) for linearity was ≥0.99. The study revealed no significant difference between the POC FinecareTM PCT and Elecsys® BRAHMS PCT immunoassay in sepsis samples from ICU patients, supported by strong correlation, minimal bias, a consistent CV, and linearity.
medicine, general & internal
What problem does this paper attempt to address?
The paper aims to address the issue of comparing the performance of two procalcitonin (PCT) testing methods in the Intensive Care Unit (ICU): the point-of-care (POC) Finecare™ Procalcitonin Rapid Quantitative Test and the laboratory-based Elecsys® BRAHMS PCT immunoassay. The study seeks to evaluate the accuracy, precision, and linearity of the Finecare POC PCT test in detecting sepsis in ICU patients and compare its results with the standard laboratory method to determine its effectiveness and reliability as a rapid diagnostic tool. This helps clinicians make faster antibiotic treatment decisions, thereby improving the management efficiency of sepsis patients.